Prosecutors say Medicare provider enrollment, reassigned billing benefits, high-cost allograft reimbursement, and a nurse-based referral network allegedly created the operational pathway through which Leigh Tesar and others extracted tens of millions from the federal program.
WASHINGTON, DC, August 14, 2026 — The Justice Department has described how ordinary Medicare Part B access, clinical credentials, provider enrollment, electronic claims processing, and relationships among nurses allegedly became interconnected components of an extraordinary wound-care billing operation centered on Sarasota nurse practitioner Leigh Tesar.
Federal prosecutors contend that Tesar used her status as an enrolled individual practitioner, reassigned her Medicare benefits to Tesar Primecare, and worked with registered nurses who identified beneficiaries whose wounds could support claims for exceptionally expensive bioengineered skin substitutes.
That structure allegedly turned access to vulnerable patients into reimbursable encounters, while Primecare served as the clinic through which it billed costly allografts and related services, producing more than $118 million in submissions over approximately eighteen months.
Medicare allegedly paid Tesar and Primecare more than $61 million before the operation ended, but access to Medicare, possession of professional licenses, high reimbursement, or participation in wound care cannot independently establish fraud or criminal intent.
Tesar, Walter Presha Junior, and Koby Evans have not been convicted, and every accusation concerning false claims, unnecessary treatment, kickbacks, falsified records, beneficiary inducements, business control, and diverted proceeds remains subject to proof in federal court.
Provider Enrollment Created the Billing Gateway
The federal indictment describing the Medicare access and billing structure states that physicians, nurse practitioners, group practices, and other qualified providers could obtain provider numbers authorizing them to submit claims for covered items and services furnished to beneficiaries.
Prosecutors allege that Tesar enrolled with Medicare as an individual practitioner and subsequently reassigned her benefits to Primecare, a Florida business registered with Medicare as a single or multispecialty clinic or group practice in Sarasota.
Reassignment generally allows an enrolled practitioner’s Medicare payments to flow through an eligible organization, creating an administrative relationship that supports group billing but also produces records connecting practitioner identity, services, claims, remittances, and the receiving business.
The indictment does not portray enrollment or reassignment as inherently improper, because both are conventional program mechanisms, yet prosecutors say Tesar falsely certified that she would obey Medicare requirements and the federal prohibition against illegal kickbacks.
That alleged certification supplies an important knowledge theory because the government may argue that Tesar understood payment depended upon truthful documentation, covered treatment, actual service delivery, medical necessity, and referral arrangements untainted by prohibited remuneration.
Primecare Centralized Claims and Payments
Primecare allegedly provided the organizational platform connecting Tesar’s practitioner status with product purchasing, treatment activity, patient records, claim submissions, and Medicare receipts, giving investigators a central business through which they could reconstruct clinical and financial evidence.
According to prosecutors, Tesar ordered expensive allografts from an unidentified Pennsylvania company, applied or purportedly applied those products to Medicare beneficiaries, and billed or caused Primecare to bill the federal program for the materials and associated services.
The clinic’s role matters because a single group practice can combine services involving multiple patients, facilities, records, products, referral sources, and payment dates, allowing legitimate care to operate efficiently while creating considerable exposure when representations are allegedly false.
Prosecutors further claim that Tesar removed her name from Florida corporate ownership records after a Medicare audit while secretly maintaining ownership and managerial control, allegedly attempting to avoid scrutiny of continuing false claim submissions through Primecare.
The defense may offer lawful explanations involving administration, licensing, financing, tax planning, or business restructuring, while contesting whether Tesar retained beneficial ownership, controlled later claims, directed employees, or intended to mislead Medicare reviewers.
Medicare Part B Paid Through a Contractor
Medicare Part B covers qualifying medical items and services furnished by physicians, nurse practitioners, group practices, and other providers when applicable rules concerning ordering, necessity, documentation, delivery, and billing have been satisfied for each beneficiary.
The program processed Florida Part B claims through First Coast Service Options, a Medicare Administrative Contractor responsible for reviewing submissions, applying coverage requirements, and issuing payments on behalf of the Centers for Medicare and Medicaid Services.
That contractor relationship meant Primecare’s claims moved through an established reimbursement channel rather than directly to an individual government official, with standardized codes and electronic data communicating what product, service, patient, practitioner, and treatment date supported payment.
Prosecutors allege the defendants exploited this claims architecture by presenting expensive allograft applications as covered care, although automated processing and administrative payment do not constitute a clinical endorsement or prevent later audit, recoupment, investigation, and prosecution.
The case therefore illustrates a distinction central to Medicare enforcement: successful payment shows that a claim passed initial processing, whereas legality ultimately depends upon the underlying facts, records, medical judgment, referral source, and truthfulness of every material representation.
Coverage Rules Were Supposed to Protect the Program
First Coast coverage rules required continuing wound treatment to be supported by documented improvement, accepted medical standards, evaluation of conditions affecting healing, and a treatment duration reasonably connected with the patient’s expected restoration potential.
For covered diabetic foot ulcers and venous leg ulcers, prosecutors cite requirements calling for at least four weeks of completed and documented conservative care, including measures such as debridement, pressure relief, infection control, and wound drainage management.
Records were also expected to explain why conservative treatment failed, while applicable policy discouraged switching skin-substitute products during a twelve-week course and treated unsuccessful repeat applications as medically unreasonable and unnecessary under specified circumstances.
Those conditions were not clerical ornaments, because they helped distinguish patients who might benefit from expensive advanced treatment from patients requiring infection control, management of underlying disease, continued conservative therapy, palliative care, or another clinical approach.
Prosecutors say the alleged operation did not merely misunderstand technical coverage language but instead generated records and claims designed to portray ineligible, unnecessary, ineffective, or nonexistent services as satisfying the program’s carefully defined payment conditions.
Nurse Relationships Allegedly Supplied Beneficiaries
The government alleges that Tesar recruited and worked with Presha and Evans, both licensed registered nurses who were presented as sales representatives, to locate Medicare beneficiaries with wounds that could lead to high-value allograft applications and claims.
Their clinical backgrounds may have provided familiarity with patients, care settings, wound conditions, medical terminology, and referral channels, although the indictment does not establish that nursing experience itself was misused in every interaction prosecutors intend to challenge.
Presha owned Universal Nursing and Wellness, while Evans owned Healing His Way, and the indictment identifies separate business names and accounts that may help investigators trace purported sales activity, referrals, payments, and alleged kickback proceeds.
The Pennsylvania allograft company allegedly entered sham sales agreements with Presha, Evans, and others, while their actual function was purportedly to refer Medicare beneficiaries to Tesar in exchange for payments tied to the resulting product business.
That alleged arrangement placed a supplier between the billing provider and the referral recipients, creating commercial paperwork that prosecutors say concealed remuneration while allowing the product company to calculate and distribute payments tied to patient and allograft invoices.
Patient Identification Allegedly Became Revenue Generation
The indictment describes communications suggesting that patient discovery was discussed in commercial terms, including an alleged message about moving through rooms looking for wounds and another introduction stating that Evans already had several potential patients available.
Prosecutors may use those communications to argue that the network began by searching for reimbursable wounds rather than through independent clinical referrals, although defense counsel can dispute the context, tone, authorship, completeness, implementation, and meaning of informal language.
Finding a patient who needs treatment is not unlawful, and nurses routinely identify conditions requiring professional attention, but compensation linked to federally reimbursable referrals can transform otherwise legitimate outreach into prohibited conduct when statutory knowledge and purpose are proven.
The government alleges that Tesar caused payments through the supplier to reward Presha and Evans for beneficiary referrals, including approximately $397,570 and approximately $10,998 transferred to their associated businesses on August 15, 2025.
Presha and Evans can challenge whether those payments represented illegal referral remuneration or compensation for legitimate sales, education, logistics, account support, product assistance, or other services, leaving purpose and knowledge as central disputed questions.
Product Pricing Allegedly Shaped Clinical Choices
Allografts can serve an important therapeutic purpose when properly selected and applied, yet their substantial per-square-centimeter prices can produce unusually large Medicare claims when extensive wounds, repeated applications, or premium products generate high billable quantities.
Prosecutors cite messages in which Tesar allegedly discussed a newer product costing $2,000 per square centimeter, compared with another priced at $1,591, while explaining that a twenty-percent payment would become significantly larger under the higher figure.
Another alleged message stated an intention to switch everyone to the costlier product, language the government may present as evidence that compensation and product economics influenced treatment selection more strongly than individualized clinical need.
The defense may argue that price discussions occur routinely among providers and suppliers, that quoted figures require context, and that prosecutors must prove actual product choices, medical decisions, claim representations, payment calculations, and criminal intent for identifiable patients.
Even troubling financial language cannot independently establish that an application was unnecessary, because the government must connect messages with medical charts, wound photographs, product orders, dates of service, lot information, billing codes, and testimony concerning actual care.
Claims Required Detailed Representations
Each Medicare submission was expected to identify the beneficiary, describe the item or service, provide appropriate billing codes, state the treatment date, and name the ordering, referring, or rendering practitioner associated with the requested reimbursement.
That information turned a clinical encounter into a payable transaction, allowing electronic claims to move quickly while creating data points investigators can later compare against charts, facility logs, supplier invoices, patient recollections, and product delivery records.
Prosecutors allege that Tesar and others falsified medical records by inventing treatments, misrepresenting prior conservative care, backdating wound documentation, and misstating patient conditions so allograft applications appeared reasonable, necessary, and compliant with coverage requirements.
They separately allege that Primecare billed for applications that were never performed, a claim that, if proven, would move beyond debatable medical judgment into the more direct question of whether the represented service occurred at all.
Defense counsel may examine who created each chart entry, whether templates produced inaccuracies, whether another clinician supplied information, whether products were delivered or used, and whether billing personnel accurately translated records into submitted codes.
Five Counts Show the Scale of Individual Claims
Five substantive health-care fraud counts identify five beneficiaries whose disputed claims sought approximately $3.96 million and allegedly produced about $2.82 million in Medicare payments, demonstrating how limited treatment episodes could generate remarkable reimbursement totals.
The largest listed claim sought approximately $1.11 million for one beneficiary and generated about $854,311, while another sought roughly $1.06 million and produced approximately $727,168 after processing through the Medicare payment system.
Those five examples represent only a fraction of the broader allegation, which involves more than $118 million billed and more than $61 million paid, so prosecutors will need evidence extending far beyond the transaction table to support the charged executions.
The scale may help a jury understand motive and program impact, but enormous numbers do not eliminate the government’s responsibility to prove knowing falsity, material representations, individual involvement, and the connection between each charged claim and Medicare money.
The defendants may separate disputed encounters from the aggregate narrative, arguing that program rules are complex, clinical opinions can differ, administrative errors occur, and lawfully provided treatment cannot become criminal merely because reimbursement was substantial.
Alleged Inducements Extended the Access Network
Prosecutors claim Tesar, the purported sales representatives, and others encouraged beneficiaries to begin or continue costly allograft treatment by misrepresenting their financial responsibility, unlawfully waiving copayments, and offering free supplies or expensive personal gifts.
The indictment identifies jewelry and a leather recliner as examples, allegations that may help the government argue patients were retained through incentives unrelated to clinical benefit while expensive claims continued flowing to Medicare.
Waiving cost sharing can obscure a beneficiary’s awareness of treatment expense and remove a program safeguard, although exceptions and individualized financial-assistance circumstances can exist, requiring careful proof about intent, representations, documentation, and applicable legal requirements.
The defense may challenge who offered each item, whether gifts were connected with treatment decisions, whether hardship policies applied, whether beneficiaries understood their obligations, and whether any inducement actually influenced a federally reimbursable service.
Patient testimony could become particularly important because beneficiaries or caregivers may describe who approached them, what was promised, whether treatment occurred, how wounds responded, what bills arrived, and whether anyone discussed copayments or provided valuable items.
Allegedly Unnecessary Treatment Created Patient Risk
The government claims allografts were applied without adequate conservative treatment, placed on infected wounds, continued after patients failed to improve, used where terminal illness prevented healing, or selected solely to maximize financial return.
If proven, those allegations would show more than financial injury because patients may have undergone burdensome procedures, experienced delayed alternative care, faced infection concerns, or received interventions inconsistent with their realistic healing potential and personal goals.
Nevertheless, outcome alone cannot establish fraud, since appropriate wound treatment sometimes fails and clinicians may disagree about prognosis, product selection, infection management, or whether an advanced therapy offered a reasonable possibility of benefit.
Expert witnesses will likely evaluate wound measurements, photographs, vascular status, diabetes control, infection indicators, prior therapies, treatment response, overall health, expected restoration, and contemporaneous records to determine whether challenged applications departed from acceptable practice.
Prosecutors must also demonstrate Tesar’s knowing participation rather than relying exclusively upon retrospective disagreement, while the defense can test whether investigators fairly selected records, interpreted policies, and distinguished poor documentation from intentional deception.
The Alleged Scheme Joined Clinical and Commercial Systems
The operational theory described by prosecutors connects five components: professional enrollment created billing eligibility, Primecare received reassigned benefits, nurses supplied prospective beneficiaries, the Pennsylvania company supplied products, and Medicare payments supported downstream financial transfers.
No single component proves wrongdoing, because each can exist lawfully within modern wound care, yet the government alleges their combination became criminal through false documentation, medically unnecessary services, nonexistent applications, kickbacks, inducements, and concealment.
This distinction is crucial for responsible reporting because phrases such as program access or billing authority should describe the mechanism allegedly exploited, not suggest that Medicare expressly authorized the disputed conduct or that nursing credentials conferred immunity.
It also explains why investigators may assemble evidence from seemingly unrelated sources, including enrollment applications, reassignment forms, corporate filings, clinical charts, product invoices, patient communications, bank transfers, text messages, and Medicare claims data.
When aligned chronologically, those records could support the government’s integrated theory, while inconsistencies, lawful revenue, legitimate referrals, missing context, or unreliable witnesses could weaken the asserted connection between access, treatment, billing, and payment.
Independent Reporting Adds Local Context
Independent Business Observer coverage of the Tampa Bay health-care cases identified the businesses associated with Tesar, Presha, and Evans while reporting that all three defendants were arrested June 18 and released under separate bonds that same day.
That local reporting also summarized the government’s allegations concerning beneficiary inducements, falsified records, infected or nonhealing wounds, more than $118 million billed, approximately $61 million paid, and potential forfeiture demands directed toward each defendant.
Public reporting must still distinguish allegations from adjudicated facts, particularly because an indictment reflects a grand jury’s charging decision rather than trial evidence tested through cross-examination, expert challenge, evidentiary rulings, and final judicial instructions.
Tesar remains presumed innocent, as do Presha and Evans, and professional credentials, businesses, provider enrollment, large payments, text messages, or seized property cannot substitute for proof beyond a reasonable doubt on criminal charges.
Program Analytics Can Follow Billing Access
Medicare claims create extensive structured data, allowing investigators to compare providers, products, patients, treatment frequency, wound size, billing codes, geography, payment velocity, and other patterns that may identify anomalies requiring clinical or financial examination.
The Justice Department announced the Tesar prosecution during its 2026 National Health Care Fraud Takedown, which charged 455 defendants across fifty-six federal districts in alleged schemes involving more than $6.5 billion in false health-care claims.
Federal officials said the nationwide operation included ninety doctors and other licensed professionals and produced seizures exceeding $182 million, reflecting an enforcement strategy combining data analytics with interviews, clinical review, financial tracing, searches, and traditional investigative methods.
Analytics can identify unusual patterns but cannot determine guilt independently, because legitimate specialists may produce outlier costs while fraudulent claims can resemble ordinary billing until records, witnesses, communications, and financial relationships provide additional context.
In Tesar’s case, investigators will need to connect aggregate patterns with specific beneficiaries and representations, ensuring that statistical suspicion becomes admissible proof rather than an assumption that unusually profitable wound care must have been criminal.
Financial Proceeds Remain Contested
The indictment seeks approximately $61.63 million from Tesar as alleged proceeds following a qualifying conviction, while separate forfeiture allegations target approximately $3.19 million from Presha and approximately $263,223 from Evans under federal criminal asset provisions.
Authorities have already seized about $11.8 million from identified bank and brokerage accounts, but a pretrial seizure preserves contested property and does not establish final forfeiture, taxpayer recovery, restitution, guilt, or a defendant’s exclusive ownership.
Prosecutors also allege Tesar and others used scheme proceeds for more than $215,000 in Tampa Bay Buccaneers tickets and luxury-suite spending, alongside fine-art purchases exceeding $400,000 during the charged operation’s eighteen-month duration.
Those lifestyle allegations may support motive or tracing, but they cannot prove that clinical services were unnecessary or claims were false, and the indictment does not identify tickets or artworks among the four specifically listed financial seizures.
The financial case will likely require account-level analysis separating Medicare receipts, product expenses, legitimate income, payroll, taxes, investment activity, owner distributions, referral payments, personal spending, and any funds subject to competing third-party interests.
Legitimate Providers Face Broader Consequences
Major fraud prosecutions can bring intensified audits, documentation demands, payment holds, reimbursement changes, and public suspicion across an entire specialty, even though most nurses and wound-care practitioners serve patients lawfully and depend upon predictable Medicare coverage.
Responsible providers can reduce exposure by preserving contemporaneous records, documenting failed conservative treatment, recording infection and underlying conditions, explaining product selection, monitoring wound improvement, separating referral compensation from clinical decisions, and auditing reassignment relationships.
They should also ensure billing personnel understand that practitioner enrollment and electronic acceptance do not cure underlying defects, because the submitting provider remains responsible for whether documentation, treatment, coding, referral arrangements, and delivery support payment.
The Amicus International Consulting news and analysis hub examines health-care fraud, regulatory enforcement, asset seizure, professional exposure, and cross-border financial investigations while distinguishing unproven allegations from guilty pleas, verdicts, dismissals, restitution, and final forfeiture.
Professionals facing sustained public scrutiny may also review Amicus International Consulting’s crisis communications and reputation-management guidance, which emphasizes verified facts, coordinated stakeholder messaging, lawful record preservation, careful media preparation, and respect for patients, investigators, regulators, and courts.
What Prosecutors Must Prove
For the health-care fraud counts, prosecutors must establish beyond a reasonable doubt that Tesar knowingly and willfully executed or attempted a scheme involving materially false representations, rather than merely showing aggressive billing, unsuccessful treatment, or incomplete documentation.
For the conspiracy and kickback allegations, the government must prove the required unlawful agreement, remuneration, referral purpose, knowledge, willfulness, and federal-program connection, tying each defendant personally to conduct prohibited by the charged statutes.
The government must connect the nurse referral network to identifiable claims and payments, show why the challenged allografts were ineligible or unperformed, authenticate communications, establish record falsification, and answer defenses involving lawful services or legitimate compensation.
Tesar can contest medical necessity, documentation authorship, claim preparation, product use, business control, message context, payment purpose, witness credibility, expert methodology, financial tracing, and the government’s interpretation of enrollment certifications and coverage requirements.
Presha and Evans may separately challenge whether they knowingly participated in an unlawful agreement, whether their payments purchased referrals, and whether their activities involved legitimate commercial, educational, logistical, or patient-support services rather than criminal inducements.
What Happens Next
The case may proceed through extensive discovery, protected medical evidence, expert review, digital communications, financial analysis, motions concerning restraints and admissibility, plea discussions, scheduling changes, evidentiary hearings, or a closely scrutinized federal jury trial.
Prosecutors will likely present the provider-access chain as one continuous system, beginning with enrollment and beneficiary identification before moving through product selection, treatment records, claims processing, Medicare payment, supplier transfers, and alleged personal benefit.
Defense lawyers will likely divide that chain into individual clinical decisions and commercial transactions, arguing that the government cannot transform administrative access, professional collaboration, or high reimbursement into proof of intentional fraud without reliable patient-specific evidence.
Major unanswered questions include how responsibilities were divided inside Primecare, who prepared particular records and claims, what services each nurse actually performed, how the supplier calculated payments, and how many billed applications prosecutors contend never occurred.
Until a guilty plea, verdict, dismissal, or other binding resolution determines criminal liability, the Medicare access described by prosecutors remains the alleged mechanism of a charged scheme, not proof that Leigh Tesar or her co-defendants committed any offense.
